We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > heart drug

News List

Why This Heart Drug Could Be a $5B Blockbuster for Novartis biospace
January 25, 2018
ZURICH (Reuters) - A Novartis executive said the Swiss company’s heart failure medicine Entresto could be used more widely in future, potentially making it a blockbuster drug with revenue potential of $4 billion to $5 billion a year.
Array Biopharma Spun Off Heart Drug R&D Into New Subsidiary Yarra Therapeutics biospace
December 28, 2017
Array BioPharma has spun out some of its intellectual property and equipment into a new company, Yarra Therapeutics. Note that Yarra is Array spelled backwards.
Common heart drug repurposed to treat rare cancer in Europe worldpharmanews
January 18, 2017
A drug that's commonly used to treat high blood pressure is being repurposed for a rare tissue cancer in Europe.